Template directed synthesis of antibody Fc conjugates with concomitant ligand release
Viktoriia Postupalenko, Léo Marx, David Viertl, Nadège Gsponer, Natalia Gasilova, Thibaut Denoël, Niklaus Schaefer, John O. Prior, Gerrit Hagens, Frédéric Lévy, Patrick Garrouste, Jean‐Manuel Segura, Origène Nyanguile
Abstract
. A Fc-III peptide was used as bait to bring a carbonate electrophilic site linked to a metal chelator and to a carboxyphenyl leaving group in close proximity with an antibody Fc nucleophile amino acid (K317), thereby triggering the covalent linkage of the chelator to the antibody lysine, with the concomitant release of the carboxyphenyl Fc-III ligand. Using CHX-A''-DTPA, we radiolabeled trastuzumab with indium-111 and showed in biodistribution and imaging experiments that the antibody accumulated successfully in the SK-OV-3 xenograft tumour implanted in mice. We found that our methodology leads to homogeneous conjugation of CHX-A''-DTPA to the antibody, and confirmed that the Fc domain can be selectively labeled at K317, with a minor level of unspecific labeling on the Fab domain. The present method can be developed as a clinical diagnostic tool to predict the success of the therapy. Furthermore, our Fc-III one step chemistry concept paves the way to a broad array of other applications in antibody bioengineering.